1,5-Anhydrosorbitol
1,5-Anhydrosorbitol structure
|
Common Name | 1,5-Anhydrosorbitol | ||
|---|---|---|---|---|
| CAS Number | 154-58-5 | Molecular Weight | 164.15600 | |
| Density | 1.533 g/cm3 | Boiling Point | 376.8ºC at 760 mmHg | |
| Molecular Formula | C6H12O5 | Melting Point | 142-143ºC | |
| MSDS | Chinese USA | Flash Point | 181.7ºC | |
|
Metabolomic profile of response to supplementation with β-carotene in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study.
Am. J. Clin. Nutr. 98(2) , 488-93, (2013) Two chemoprevention trials found that supplementation with β-carotene increased the risk of lung cancer and overall mortality. The biologic basis of these findings remains poorly understood.The objective was to compare the on-study change in metabolomic profi... |
|
|
Relationship between postprandial glucose level and carotid artery stiffness in patients without diabetes or cardiovascular disease.
BMC Cardiovasc. Disord. 13 , 11, (2013) The aim of this study was to evaluate the relationship between postprandial glucose level and atherosclerosis in patients without diabetes and cardiovascular disease by determining carotid ultrasonographic variables and serum levels of 1,5-anhydroglucitol (1,... |
|
|
Effects of bile-acid-binding resin (colestimide) on blood glucose and visceral fat in Japanese patients with type 2 diabetes mellitus and hypercholesterolemia: an open-label, randomized, case-control, crossover study.
J. Diabetes Complications 26(1) , 34-9, (2012) The objective was to examine the effects of colestimide on blood glucose, visceral fat, adipocytokines, and bile acid conjugate fractions in Japanese patients.This study was an open-label, randomized, case-control, crossover study of colestimide 3 g/day in 40... |
|
|
Improved Insulin Secretion by Autologous Islet Transplantation, Compared to Oral Antidiabetic Agents, After Distal Pancreatectomy.
Cell. Transplant. 24 , 1615-26, (2015) In this study, the effects of autologous islet transplantation (ITx) were compared to those of oral antidiabetic drugs (OAD) after distal pancreatectomy (NCT01922492). We enrolled nondiabetic patients who underwent distal pancreatectomy for benign tumors. In ... |
|
|
A study on the association of serum 1,5-anhydroglucitol levels and the hyperglycaemic excursions as measured by continuous glucose monitoring system among people with type 2 diabetes in China.
Diabetes. Metab. Res. Rev. 28(4) , 357-62, (2012) Blood glucose excursion is an important component of the glycaemic burden, but there are no indexes that can directly reflect them. The aim was to evaluate the values and significance of serum 1,5-anhydroglucitol (1,5-AG) in people with type 2 diabetes mellit... |
|
|
Increased 1,5-anhydroglucitol predicts glycemic remission in patients with newly diagnosed type 2 diabetes treated with short-term intensive insulin therapy.
Diabetes Technol. Ther. 14(9) , 756-61, (2012) Short-term intensive insulin therapy has been shown to induce long-term glycemic remission in patients with newly diagnosed type 2 diabetes. However, predictors of remission are still uncertain. This study was conducted to evaluate whether changes of 1,5-anhy... |
|
|
Clinical and forensic examinations of glycemic marker 1,5-anhydroglucitol by means of high performance liquid chromatography tandem mass spectrometry.
Forensic Sci. Int. 222(1-3) , 132-6, (2012) Postmortem diagnosis of diabetes and a diabetic coma can be difficult because of the lack of characteristic morphological findings. 1,5-Anhydroglucitol (1,5-AG), the 1-deoxy form of glucose, competes with glucose for reabsorption in the kidneys. Therefore, di... |
|
|
Effects of miglitol in combination with intensive insulin therapy on blood glucose control with special reference to incretin responses in type 1 diabetes mellitus.
Endocr. J. 58(10) , 869-77, (2011) To determine whether miglitol administration improves glycemic control and reduces the frequency of hypoglycemia in type 1 diabetes mellitus (T1DM) patients treated with intensive insulin therapy, we analyzed the effect of miglitol on daily insulin doses, bod... |
|
|
Potential for use of 1,5-anhydroglucitol when initiating insulin therapy in people with type 2 diabetes and suboptimal control with oral antidiabetic drugs.
Diabetes Res. Clin. Pract. 96(3) , e66-9, (2012) Endpoint HbA(1c) <7.0% was achieved by 80 (73.4%) lispro mix 25 (LM25)-treated patients and 67 (60.9%) glargine-treated patients (p=0.027) with baseline 1,5 anhydroglucitol (1,5AG) below median and 75 (70.8%) LM25-treated patients and 72 (63.7%) glargine-trea... |
|
|
Correlation between 1,5-anhydroglucitol and glycemic excursions in type 2 diabetic patients.
Chin. Med. J. 124(22) , 3641-5, (2011) The accurate and comprehensive assessment of glycemic control in patients with diabetes is important for optimizing glycemic management and for formulating personalized diabetic treatment schemes. This study aimed to analyze the correlation between 1,5-anhydr... |